Portal:Disease/COVIDPathways
From WikiPathways
Line 42: | Line 42: | ||
{| style="margin: 10px; background-color:#AFDCDE" | {| style="margin: 10px; background-color:#AFDCDE" | ||
|width=100px|{{#pwImage:Pathway:WP4890|250px||COVID19 AOP}} | |width=100px|{{#pwImage:Pathway:WP4890|250px||COVID19 AOP}} | ||
+ | Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways | ||
|- | |- | ||
|} | |} |
Revision as of 12:38, 7 April 2020
This special subset of disease pathways is being highlighted during the current COVID-19 crisis. This content is released under a CC0 waiver to be freely used, reused and distributed. Let us know if you add a new pathway or want to recommend one for this collection. |
Image does not exist Collaborative project for curation biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with muliple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist The interferon-MAPK pathway in response to SARS-CoV-2 infection. |
Image does not exist Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
More about ACE2
Image does not exist |
Image does not exist |